4.5 Article

D-allose enhances the efficacy of hydroxychloroquine against Lewis lung carcinoma cell growth by inducing autophagy

Journal

ONCOLOGY REPORTS
Volume 47, Issue 6, Pages -

Publisher

SPANDIDOS PUBL LTD
DOI: 10.3892/or.2022.8328

Keywords

D-allose; autophagy; rare sugar; Lewis lung carcinoma cells; hydroxychloroquine

Categories

Ask authors/readers for more resources

D-Allose, a rare sugar, can inhibit tumor cell growth by blocking glucose uptake. However, some cells develop resistance to D-Allose. In this study, the researchers established a D-Allose-resistant tumor cell line and a mouse xenograft model. They found that combined treatment with D-Allose and an autophagy inhibitor effectively suppressed tumor growth and selectively induced autophagy at the tumor site.
Various cancer cells require massive amounts of glucose as an energy source for their dysregulated growth. Although D-allose, a rare sugar, inhibits tumor cell growth via inhibition of glucose uptake, a few cells can survive after treatment. However, the mechanism by which D-allose-resistant cells are generated remains unclear. Here, we investigated the properties of D-allose-resistant cells and evaluated the efficacy of combined treatment with this rare sugar and antitumor drugs. To this end, we established a D-allose-resistant tumor cell line and prepared a C57BL/6J mouse tumor xenograft model using Lewis lung carcinoma (LLC) cells. Xenograft-bearing mice were treated with D-allose (9 g/kg) and/or hydroxychloroquine (HCQ, 60 mg/kg), an autophagy inhibitor, for two weeks. Although D-allose inhibited LLC cell growth in a dose-dependent manner, a few cells survived. The upregulation of LC3-II, a classical autophagy marker, and the downregulation of mTOR and its downstream molecule Beclin1 were observed in established D-allose-resistant LLC cells, which were more sensitive to cell death induced by HCQ. Similarly, in the tumor xenograft model, the tumor volume in mice co-treated with D-allose and HCQ was considerably smaller than that in untreated or HCQ-treated mice. Importantly, the administration of D-allose induced autophagy selectively at the tumor site of the xenograft-bearing mice. These results provide a new therapeutic strategy targeting autophagy which is induced in tumor cells by D-allose administration, and may be used to improve therapies for lung cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available